Overview

Kidney Damage In Patients With Severe Fall In eGFR

Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a pilot study using a randomized, double blinded, comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have and estimated glomerular filtration [eGFR] < 30 mL/min/1.73 m2. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.
Phase:
Phase 4
Details
Lead Sponsor:
Bracco Diagnostics, Inc